MYC expression is not typically altered in MGUS but is upregulated in around 70% of patients newly diagnosed with MM and is believed to drive MM cell dependence on glutamine metabolism through mechanisms promoting the transcription of the cell membrane glutamine importers ASCT2 and SN2 [31]. This evidence concerns the gene MYC and Miyoshi myopathy.